Efficacy and Safety Of Obinutuzumab in Active Lupus nephritis
Starting on:
Jan 28, 2026
Ending on:
Jan 28, 2026
Moderator(s):
Dr. Cathy Melong
Consultant Rheumatologist
Venue:

Max Credits:
3 Points

Provider:
The Mater Hospital
Claim Points

Efficacy and Safety Of Obinutuzumab in Active Lupus nephritis

Starting on:
Jan 28, 2026
Ending on:
Jan 28, 2026
Venue:

Description

Efficacy and Safety Of Obinutuzumab in Active Lupus nephritis

Objectives

Efficacy and Safety Of Obinutuzumab in Active Lupus nephritis

Presenters

  1. Dr. Titus Muhari
    ECSACOP resident
    The Mater Hospital

Search For CPD Activity